BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22043288)

  • 1. Bioenergetic consequences of PINK1 mutations in Parkinson disease.
    Abramov AY; Gegg M; Grunewald A; Wood NW; Klein C; Schapira AH
    PLoS One; 2011; 6(10):e25622. PubMed ID: 22043288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.
    Grünewald A; Gegg ME; Taanman JW; King RH; Kock N; Klein C; Schapira AH
    Exp Neurol; 2009 Sep; 219(1):266-73. PubMed ID: 19500570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance.
    Heeman B; Van den Haute C; Aelvoet SA; Valsecchi F; Rodenburg RJ; Reumers V; Debyser Z; Callewaert G; Koopman WJ; Willems PH; Baekelandt V
    J Cell Sci; 2011 Apr; 124(Pt 7):1115-25. PubMed ID: 21385841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
    Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
    Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respiration.
    Stauch KL; Villeneuve LM; Purnell PR; Ottemann BM; Emanuel K; Fox HS
    Proteomics Clin Appl; 2016 Dec; 10(12):1205-1217. PubMed ID: 27568932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical properties of the kinase PINK1 as sensor protein for mitochondrial damage signalling.
    Rüb C; Schröder N; Voos W
    Biochem Soc Trans; 2015 Apr; 43(2):287-91. PubMed ID: 25849931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.
    Exner N; Treske B; Paquet D; Holmström K; Schiesling C; Gispert S; Carballo-Carbajal I; Berg D; Hoepken HH; Gasser T; Krüger R; Winklhofer KF; Vogel F; Reichert AS; Auburger G; Kahle PJ; Schmid B; Haass C
    J Neurosci; 2007 Nov; 27(45):12413-8. PubMed ID: 17989306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of mitochondrial permeability transition pore by PINK1.
    Gautier CA; Giaime E; Caballero E; Núñez L; Song Z; Chan D; Villalobos C; Shen J
    Mol Neurodegener; 2012 May; 7():22. PubMed ID: 22630785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
    Gispert S; Ricciardi F; Kurz A; Azizov M; Hoepken HH; Becker D; Voos W; Leuner K; Müller WE; Kudin AP; Kunz WS; Zimmermann A; Roeper J; Wenzel D; Jendrach M; García-Arencíbia M; Fernández-Ruiz J; Huber L; Rohrer H; Barrera M; Reichert AS; Rüb U; Chen A; Nussbaum RL; Auburger G
    PLoS One; 2009 Jun; 4(6):e5777. PubMed ID: 19492057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
    Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
    Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.
    Morais VA; Verstreken P; Roethig A; Smet J; Snellinx A; Vanbrabant M; Haddad D; Frezza C; Mandemakers W; Vogt-Weisenhorn D; Van Coster R; Wurst W; Scorrano L; De Strooper B
    EMBO Mol Med; 2009 May; 1(2):99-111. PubMed ID: 20049710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.
    Akundi RS; Huang Z; Eason J; Pandya JD; Zhi L; Cass WA; Sullivan PG; Büeler H
    PLoS One; 2011 Jan; 6(1):e16038. PubMed ID: 21249202
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
    Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N).
    Abdul MM; Ibañez DP; Zhao P; Liu H; Zhong X; Li Y; Zhang M; Li W; Li Y; Ward C; Chen S; Wang D; Qin B; Esteban MA; Wang X; Fan W; Luo Z
    Stem Cell Res; 2019 Dec; 41():101607. PubMed ID: 31778937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.
    Giguère N; Pacelli C; Saumure C; Bourque MJ; Matheoud D; Levesque D; Slack RS; Park DS; Trudeau LÉ
    J Biol Chem; 2018 Jun; 293(25):9580-9593. PubMed ID: 29700116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.
    Gautier CA; Kitada T; Shen J
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11364-9. PubMed ID: 18687901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heterozygous effect for PINK1 mutations in Parkinson's disease?
    Abou-Sleiman PM; Muqit MM; McDonald NQ; Yang YX; Gandhi S; Healy DG; Harvey K; Harvey RJ; Deas E; Bhatia K; Quinn N; Lees A; Latchman DS; Wood NW
    Ann Neurol; 2006 Oct; 60(4):414-9. PubMed ID: 16969854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of early-onset familial PD].
    Sato S
    Rinsho Shinkeigaku; 2012; 52(11):1327-8. PubMed ID: 23196607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.